NEWS
Latest News and Information
A Season of Gratitude: Why My Family Supports LuMind IDSC
Thirty years ago, our family plans changed when our first child, Gwendolyn, was born with Down syndrome. Over time, we
Angie Del Gaudio Awarded Collin Lis Humanitarian Award
Angie Del Gaudio from Long Beach, CA has been selected as the 2024 Collin Lis Humanitarian Award winner. Del Gaudio
RAND report shows benefit of investment in future health outcomes for adults with Down syndrome
10/1/2024 | For immediate release | Contact: Kate O’Neill ([email protected]) Investment in Alzheimer’s Research Today Will Yield Health Benefits for
His Amazing Self: a brother’s reflection on Down syndrome-associated Alzheimer’s Disease
My brother, Rohan, was born 38 years ago in the city of Bangalore in India. He was born with Down
Pathways to Parity Program Approved for $250K PCORI Engagement Award
Project will empower advocates, enhance research for people at high risk of Alzheimer’s disease who have Down syndrome Washington, D.C.
Updates from AAIC: Down syndrome community boosted by FDA confirmation of label and new anti-amyloid clinical trial
Information revealed at the 2024 AAIC conference on the ACTC-DS-led study in DS-associated Alzheimer’s disease with Lilly’s anti-amyloid drug Kisunla.
LuMind IDSC Presents the Collin Lis Humanitarian Award to Two Employees
In honor of Collin Lis, a kind and loving 11-year-old boy with Down syndrome, LuMind IDSC is presenting the Collin
FDA issues approval for new Alzheimer’s drug Kisunla; Down syndrome community is optimistic
FDA issues approval for Kisunla, new Alzheimer’s drug; Down syndrome community optimistic On Tuesday, July 2, the U.S. Food and
Navigating the Road to Graduation for Students with Disabilities
Graduation from high school is a major accomplishment in the journey we each experience through life. According to the U.S.
Down syndrome population will see a clinical trial of new Alzheimer’s drug
Major pharmaceutical company announces Down syndrome population will see a clinical trial of new Alzheimer’s drug People with Down syndrome
Clinical Trials Day: A Historic Review of the First Clinical Trial
James Lind, a United Kingdom’s Royal Navy surgeon, is considered the “Father of Clinical Trials.” Each year, on May 20,
An Everyday Hero in Mom: Navigating Down Syndrome Regression Disorder
There is a quote from author Lance Conrad that states, “I can imagine no heroism greater than motherhood.” For Cristina